Two-stage management of chronic osteomyelitis of the long bones. The Belfast technique

1993 ◽  
Vol 75-B (3) ◽  
pp. 375-380 ◽  
Author(s):  
MA McNally ◽  
JO Small ◽  
HG Tofighi ◽  
RA Mollan
Injury ◽  
2017 ◽  
Vol 48 (2) ◽  
pp. 511-518 ◽  
Author(s):  
Hongri Wu ◽  
Jie Shen ◽  
Xin Yu ◽  
Jingshu Fu ◽  
Shengpeng Yu ◽  
...  

Neurosurgery ◽  
2006 ◽  
Vol 58 (6) ◽  
pp. E1219-E1219 ◽  
Author(s):  
Hiroyuki Nakase ◽  
Ryosuke Matsuda ◽  
Ryo Tamaki ◽  
Rinsei Tei ◽  
Young-Su Park ◽  
...  

2021 ◽  
Vol 19 (3) ◽  
pp. 144-151
Author(s):  
P. E. ELDZAROV ◽  

The work is devoted to improving the effectiveness of treatment of patients with complications and consequences of fractures of the long bones of the extremities by improving and developing new surgical techniques aimed at early individual social and household rehabilitation due to the maximally complete and rapid restoration of the integrity and functions of the damaged segment. Reconstructive operations were performed in 285 patients with delayed fracture consolidation, incorrectly fused fractures, false joints, and false joints with chronic osteomyelitis. The analysis of the applied treatment methods effectiveness from the viewpoint of optimizing the treatment process allowed us to develop an algorithm for the surgical treatment of patients with complications and consequences of fractures of the long bones of the extremities. The use of the proposed algorithm in surgical treatment maximally eliminates possible errors and increases the treatment effectiveness.


2004 ◽  
Vol 17 (4) ◽  
pp. 395 ◽  
Author(s):  
Se Hyun Cho ◽  
Soon Taek Jeong ◽  
Hyung Bin Park ◽  
Sun Chul Hwang ◽  
Yong Chan Ha ◽  
...  

The Lancet ◽  
1928 ◽  
Vol 211 (5454) ◽  
pp. 490-491
Author(s):  
H. Hallilay

Materials ◽  
2019 ◽  
Vol 12 (19) ◽  
pp. 3209 ◽  
Author(s):  
Jan Geurts ◽  
Tom van Vugt ◽  
Eline Thijssen ◽  
Jacobus J. Arts

This study was set up to evaluate the costs of a one-stage treatment of chronic osteomyelitis using bioactive glass S53P4 versus a two-stage treatment using gentamicin-loaded PMMA beads. Furthermore, a cost-effectiveness analysis was performed from a hospital’s perspective together with the evaluation of clinical outcome. A treatment group (n = 25) receiving one-stage surgery with bioactive glass was retrospectively compared with a two-stage control group (n = 25). An assessment was made of all costs included from first outpatient visit until one year after treatment. Bootstrap simulation and sensitivity analyses were performed. The primary endpoint was cost-effectiveness with clinical outcome as the secondary endpoint. The base case analyses shows dominance of the one-stage treatment with bioactive glass S53P4 due to lower costs and a better clinical outcome. Sensitivity analyses confirm these findings. This study is the first in its kind to show one-stage treatment of chronic osteomyelitis with bioactive glass S53P4 to be cost-effective.


Sign in / Sign up

Export Citation Format

Share Document